Skip to content
10-K/A

Annual Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001354488-13-002122

← back to feed
Filed
Apr 22, 2013 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Apr 15, 2013 52.19M sh
Capex FY 2012 · Dec 31, 2012 $385.1K
Capex FY 2012 · Dec 31, 2011 $320.12K
Operating Cash Flow FY 2012 · Dec 31, 2012 $2.01M
Operating Cash Flow FY 2012 · Dec 31, 2011 −$746.81K
Stockholders Equity FY 2012 · Dec 31, 2012 $10.95M
Stockholders Equity FY 2012 · Dec 31, 2011 $7.53M
Stockholders Equity FY 2012 · Dec 31, 2010 $7.58M
Current Liabilities FY 2012 · Dec 31, 2012 $9.54M
Current Liabilities FY 2012 · Dec 31, 2011 $10.32M
Total Liabilities FY 2012 · Dec 31, 2012 $9.54M
Total Liabilities FY 2012 · Dec 31, 2011 $10.32M
Current Assets FY 2012 · Dec 31, 2012 $13.2M
Current Assets FY 2012 · Dec 31, 2011 $10.44M
Total Assets FY 2012 · Dec 31, 2012 $20.49M
Total Assets FY 2012 · Dec 31, 2011 $17.85M
Sga Expense FY 2012 · Dec 31, 2012 $3.19M
Sga Expense FY 2012 · Dec 31, 2011 $2.38M
Rd Expense FY 2012 · Dec 31, 2012 $43.53K
Rd Expense FY 2012 · Dec 31, 2011 $67.64K
Net Income FY 2012 · Dec 31, 2012 $961.12K
Net Income FY 2012 · Dec 31, 2011 −$214.05K
Operating Income FY 2012 · Dec 31, 2012 $1.02M
Operating Income restated FY 2012 · Dec 31, 2011 $624.41K
Gross Profit FY 2012 · Dec 31, 2012 $6.76M
Gross Profit FY 2012 · Dec 31, 2011 $6M
Revenue FY 2012 · Dec 31, 2012 $13.92M
Revenue FY 2012 · Dec 31, 2011 $12.55M
Cash And Equivalents FY 2012 · Dec 31, 2011 $3.1M
Cash And Equivalents FY 2012 · Dec 31, 2010 $1.39M